Download PDF
Am J Perinatol 2015; 32(12): 1145-1150
DOI: 10.1055/s-0035-1549397
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Endocannabinoid Levels in Newborns in Relation to the Mode of Delivery

Viktoria Jokisch
1   Clinic of Neonatology, University Medical Center Mannheim, Mannheim, Germany
,
Richard Kroll
2   Department of Pediatric Surgery, University Medical Center Mannheim, Mannheim, Germany
,
Beat Lutz
3   Institute of Physiological Chemistry, University Medical Center Mainz of the Johannes Gutenberg University, Mainz, Germany
,
Laura Bindila
3   Institute of Physiological Chemistry, University Medical Center Mainz of the Johannes Gutenberg University, Mainz, Germany
,
Regine Schaffelder
4   Department of Obstetrics and Gynaecology, University Medical Center Mannheim, Mannheim, Germany
,
Thomas Schaible
1   Clinic of Neonatology, University Medical Center Mannheim, Mannheim, Germany
› Author Affiliations
Further Information

Publication History

22 January 2015

06 March 2015

Publication Date:
27 April 2015 (online)

    Permissions and Reprints

Abstract

Objective This study aims to examine the endocannabinoid levels in newborns in relation to the mode of delivery.

Study Design In this study, the concentrations of the endocannabinoids anandamide (AEA), 2-arachidonylglycerol (2-AG), palmitoylethanolamine (PEA), and the metabolite arachidonic acid (AA) in umbilical cord vein blood of 49 newborns was determined by quantitative mass spectrometry using liquid chromatography multiple reaction monitoring. The newborns were divided by their mode of delivery. Only healthy newborns born after 340/7 gestational weeks without birth complications were included.

Results The concentration of AEA, PEA, and AA was significantly higher in vaginal delivered newborns (n = 25) in comparison to newborns born by cesarean delivery (n = 24). 2-AG exhibited no significant differences between the groups.

Conclusion The exposure of the newborn to high endocannabinoid concentrations is a physiological process during vaginal delivery. The endocannabinoids AEA, PEA, and their metabolite AA seem to be part of an endocrine system during labor and birth supporting the fetal transition.

Keywords

mode of delivery - endocannabinoids - newborn - labor - fetal transition
 

  • References

  • 1 Devane WA, Hanus L, Breuer A , et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258 (5090) 1946-1949
    CrossrefPubMedGoogle Scholar
  • 2 Sugiura T, Kondo S, Sukagawa A , et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995; 215 (1) 89-97
    CrossrefPubMedGoogle Scholar
  • 3 Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006; 58 (3) 389-462
    CrossrefPubMedGoogle Scholar
  • 4 Zogopoulos P, Vasileiou I, Patsouris E, Theocharis S. The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects. J Appl Toxicol 2013; 33 (4) 246-264
    CrossrefPubMedGoogle Scholar
  • 5 Guindon J, Hohmann AG. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol 2008; 153 (2) 319-334
    CrossrefPubMedGoogle Scholar
  • 6 Häring M, Guggenhuber S, Lutz B. Neuronal populations mediating the effects of endocannabinoids on stress and emotionality. Neuroscience 2012; 204: 145-158
    CrossrefPubMedGoogle Scholar
  • 7 Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 2006; 27 (1) 73-100
    CrossrefPubMedGoogle Scholar
  • 8 Habayeb OM, Taylor AH, Finney M, Evans MD, Konje JC. Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. JAMA 2008; 299 (10) 1135-1136
    CrossrefPubMedGoogle Scholar
  • 9 Maccarrone M, Bisogno T, Valensise H , et al. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol Hum Reprod 2002; 8 (2) 188-195
    CrossrefPubMedGoogle Scholar
  • 10 Habayeb OM, Taylor AH, Evans MD , et al. Plasma levels of the endocannabinoid anandamide in women—a potential role in pregnancy maintenance and labor?. J Clin Endocrinol Metab 2004; 89 (11) 5482-5487
    CrossrefPubMedGoogle Scholar
  • 11 Lam PM, Marczylo TH, El-Talatini M , et al. Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma. Anal Biochem 2008; 380 (2) 195-201
    CrossrefPubMedGoogle Scholar
  • 12 Vogeser M, Hauer D, Christina Azad S, Huber E, Storr M, Schelling G. Release of anandamide from blood cells. Clin Chem Lab Med 2006; 44 (4) 488-491
    CrossrefPubMedGoogle Scholar
  • 13 Lomazzo E, Bindila L, Remmers F , et al. Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain. Neuropsychopharmacology 2015; 40 (2) 488-501
    CrossrefPubMedGoogle Scholar
  • 14 Nallendran V, Lam PM, Marczylo TH , et al. The plasma levels of the endocannabinoid, anandamide, increase with the induction of labour. BJOG 2010; 117 (7) 863-869
    CrossrefPubMedGoogle Scholar
  • 15 Marczylo TH, Lam PM, Amoako AA, Konje JC. Anandamide levels in human female reproductive tissues: solid-phase extraction and measurement by ultraperformance liquid chromatography tandem mass spectrometry. Anal Biochem 2010; 400 (2) 155-162
    CrossrefPubMedGoogle Scholar
  • 16 Dalterio SL. Cannabinoid exposure: effects on development. Neurobehav Toxicol Teratol 1986; 8 (4) 345-352
    PubMedGoogle Scholar
  • 17 Bland RD, Bressack MA, McMillan DD. Labor decreases the lung water content of newborn rabbits. Am J Obstet Gynecol 1979; 135 (3) 364-367
    PubMedGoogle Scholar
  • 18 Graves BW, Haley MM. Newborn transition. J Midwifery Womens Health 2013; 58 (6) 662-670
    CrossrefPubMedGoogle Scholar
  • 19 Nielsen TF, Hökegård KH. The incidence of acute neonatal respiratory disorders in relation to mode of delivery. Acta Obstet Gynecol Scand 1984; 63 (2) 109-114
    CrossrefPubMedGoogle Scholar
  • 20 Hansen AK, Wisborg K, Uldbjerg N, Henriksen TB. Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study. BMJ 2008; 336 (7635) 85-87
    CrossrefPubMedGoogle Scholar
  • 21 Levine EM, Ghai V, Barton JJ, Strom CM. Mode of delivery and risk of respiratory diseases in newborns. Obstet Gynecol 2001; 97 (3) 439-442
    CrossrefPubMedGoogle Scholar
  • 22 Kopczyńska B, Sulejczak D, Wełniak-Kamińska M, Gietka A, Grieb P. Anandamide enhances expression of heat shock proteins Hsp70 and Hsp25 in rat lungs. Eur J Pharmacol 2011; 668 (1-2) 257-263
    CrossrefPubMedGoogle Scholar
  • 23 Wenzel D, Matthey M, Bindila L , et al. Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction. Proc Natl Acad Sci U S A 2013; 110 (46) 18710-18715
    CrossrefPubMedGoogle Scholar
  • 24 Panikashvili D, Shein NA, Mechoulam R , et al. The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol Dis 2006; 22 (2) 257-264
    CrossrefPubMedGoogle Scholar
  • 25 Schomacher M, Müller HD, Sommer C, Schwab S, Schäbitz WR. Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia. Brain Res 2008; 1240: 213-220
    CrossrefPubMedGoogle Scholar
  • 26 Zani A, Braida D, Capurro V, Sala M. Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors. Br J Pharmacol 2007; 152 (8) 1301-1311
    CrossrefPubMedGoogle Scholar
  • 27 Alonso-Alconada D, Alvarez A, Hilario E. Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury. Neurosci Bull 2011; 27 (4) 275-285
    CrossrefPubMedGoogle Scholar
  • 28 Arikan GM, Scholz HS, Petru E, Haeusler MC, Haas J, Weiss PA. Cord blood oxygen saturation in vigorous infants at birth: what is normal?. BJOG 2000; 107 (8) 987-994
    CrossrefPubMedGoogle Scholar
  • 29 Helwig JT, Parer JT, Kilpatrick SJ, Laros Jr RK. Umbilical cord blood acid-base state: what is normal?. Am J Obstet Gynecol 1996; 174 (6) 1807-1812 , discussion 1812–1814
    CrossrefPubMedGoogle Scholar
  • 30 Kotaska K, Urinovska R, Klapkova E, Prusa R, Rob L, Binder T. Re-evaluation of cord blood arterial and venous reference ranges for pH, pO(2), pCO(2), according to spontaneous or cesarean delivery. J Clin Lab Anal 2010; 24 (5) 300-304
    CrossrefPubMedGoogle Scholar
  • 31 Hannah ME, Hannah WJ, Hewson SA, Hodnett ED, Saigal S, Willan AR ; Term Breech Trial Collaborative Group. Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Lancet 2000; 356 (9239) 1375-1383
    CrossrefPubMedGoogle Scholar
  • 32 Watanabe K, Iwasaki A, Mori T , et al. Differences in levels of oxidative stress in mothers and neonate: the impact of mode of delivery. J Matern Fetal Neonatal Med 2013; 26 (16) 1649-1652
    CrossrefPubMedGoogle Scholar
  • 33 Saphier O, Schneid-Kofman N, Silberstein E, Silberstein T. Does mode of delivery affect neonate oxidative stress in parturition? Review of literature. Arch Gynecol Obstet 2013; 287 (3) 403-406
    CrossrefPubMedGoogle Scholar
  • 34 Díaz-Castro J, Florido J, Kajarabille N , et al. The timing of cord clamping and oxidative stress in term newborns. Pediatrics 2014; 134 (2) 257-264
    CrossrefPubMedGoogle Scholar
  • 35 Ochoa JJ, Ramirez-Tortosa MC, Quiles JL , et al. Oxidative stress in erythrocytes from premature and full-term infants during their first 72 h of life. Free Radic Res 2003; 37 (3) 317-322
    CrossrefPubMedGoogle Scholar
  • 36 Tantimonaco M, Ceci R, Sabatini S , et al. Physical activity and the endocannabinoid system: an overview. Cell Mol Life Sci 2014; 71 (14) 2681-2698
    CrossrefPubMedGoogle Scholar
  • 37 Nunn AV, Guy GW, Bell JD. Endocannabinoids, FOXO and the metabolic syndrome: redox, function and tipping point—the view from two systems. Immunobiology 2010; 215 (8) 617-628
    CrossrefPubMedGoogle Scholar
  • 38 Lara-Celador I, Castro-Ortega L, Alvarez A, Goñi-de-Cerio F, Lacalle J, Hilario E. Endocannabinoids reduce cerebral damage after hypoxic-ischemic injury in perinatal rats. Brain Res 2012; 1474: 91-99
    CrossrefPubMedGoogle Scholar
  • 39 Vogl SE, Worda C, Egarter C , et al. Mode of delivery is associated with maternal and fetal endocrine stress response. BJOG 2006; 113 (4) 441-445
    CrossrefPubMedGoogle Scholar
  • 40 Mears K, McAuliffe F, Grimes H, Morrison JJ. Fetal cortisol in relation to labour, intrapartum events and mode of delivery. J Obstet Gynaecol 2004; 24 (2) 129-132
    CrossrefPubMedGoogle Scholar
  • 41 McPartland JM, Guy GW, Di Marzo V. Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system. PLoS ONE 2014; 9 (3) e89566
    CrossrefPubMedGoogle Scholar
  • 42 Vaughn LK, Denning G, Stuhr KL, de Wit H, Hill MN, Hillard CJ. Endocannabinoid signalling: has it got rhythm?. Br J Pharmacol 2010; 160 (3) 530-543
    CrossrefPubMedGoogle Scholar
  • 43 Martínez-Vargas M, Murillo-Rodríguez E, González-Rivera R , et al. Sleep modulates cannabinoid receptor 1 expression in the pons of rats. Neuroscience 2003; 117 (1) 197-201
    CrossrefPubMedGoogle Scholar
  • 44 Morrison JJ, Rennie JM, Milton PJ. Neonatal respiratory morbidity and mode of delivery at term: influence of timing of elective caesarean section. Br J Obstet Gynaecol 1995; 102 (2) 101-106
    CrossrefPubMedGoogle Scholar
  • 45 Berrendero F, Sepe N, Ramos JA, Di Marzo V, Fernández-Ruiz JJ. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 1999; 33 (3) 181-191
    Google Scholar